Non-Small-Cell Lung Cancer

Category: Medical

ASO Keyword Dashboard

Tracking 44 keywords for Non-Small-Cell Lung Cancer in Apple App Store

Developer: Med Learning Group Category: medical

Non-Small-Cell Lung Cancer tracks 44 keywords (1 keyword ranks; 43 need traction). Key metrics: 0% top-10 coverage, opportunity 70.5, difficulty 38.5, best rank 57.

Tracked keywords

1 ranked • 43 not ranking yet

Top 10 coverage

Best rank 57 • Latest leader —

Avg opportunity

70.5

Top keyword: continue

Avg difficulty

38.5

Lower scores indicate easier wins

Opportunity leaders

continue

Opportunity: 73.0 • Difficulty: 41.6 • Rank —

Competitors: 189
68.3
addition

Opportunity: 73.0 • Difficulty: 42.1 • Rank —

Competitors: 148
68.7
improved

Opportunity: 73.0 • Difficulty: 39.4 • Rank —

Competitors: 129
64.0
target

Opportunity: 73.0 • Difficulty: 40.4 • Rank —

Competitors: 123
66.4
known

Opportunity: 73.0 • Difficulty: 41.6 • Rank —

Competitors: 180
67.8

Unranked opportunities

continue

Opportunity: 73.0 • Difficulty: 41.6 • Competitors: 189
addition

Opportunity: 73.0 • Difficulty: 42.1 • Competitors: 148
improved

Opportunity: 73.0 • Difficulty: 39.4 • Competitors: 129
target

Opportunity: 73.0 • Difficulty: 40.4 • Competitors: 123
known

Opportunity: 73.0 • Difficulty: 41.6 • Competitors: 180

High competition keywords

using

Total apps: 115,216 • Major competitors: 1,470

Latest rank: — • Difficulty: 51.8
whether

Total apps: 89,905 • Major competitors: 1,070

Latest rank: — • Difficulty: 50.6
making

Total apps: 56,675 • Major competitors: 744

Latest rank: — • Difficulty: 48.4
various

Total apps: 48,900 • Major competitors: 673

Latest rank: — • Difficulty: 47.5
well

Total apps: 43,962 • Major competitors: 485

Latest rank: — • Difficulty: 47.0

All tracked keywords

Includes opportunity, difficulty, rankings and competitor benchmarks

							Major Competitors
non	71	100	36	58 2,921 competing apps Median installs: 100 Avg rating: 4.2	57	57	57 major competitor apps
whether	67	100	51	83 89,905 competing apps Median installs: 150 Avg rating: 4.3	—	—	1,070 major competitor apps
medical	71	100	43	72 19,329 competing apps Median installs: 150 Avg rating: 4.2	—	—	130 major competitor apps
management	69	100	47	77 42,389 competing apps Median installs: 75 Avg rating: 4.1	—	—	304 major competitor apps
avoid	72	100	43	71 17,380 competing apps Median installs: 200 Avg rating: 4.1	—	—	302 major competitor apps
using	66	100	52	85 115,216 competing apps Median installs: 150 Avg rating: 4.1	—	—	1,470 major competitor apps
variety	69	100	47	77 39,534 competing apps Median installs: 200 Avg rating: 4.2	—	—	828 major competitor apps
program	72	100	44	71 17,296 competing apps Median installs: 150 Avg rating: 4.1	—	—	220 major competitor apps
various	69	100	48	78 48,900 competing apps Median installs: 150 Avg rating: 4.1	—	—	673 major competitor apps
continue	73	100	42	68 11,994 competing apps Median installs: 200 Avg rating: 4.2	—	—	189 major competitor apps
main	71	100	44	72 20,553 competing apps Median installs: 150 Avg rating: 4.1	—	—	203 major competitor apps
look	69	100	47	77 37,399 competing apps Median installs: 225 Avg rating: 4.1	—	—	731 major competitor apps
well	69	100	47	78 43,962 competing apps Median installs: 150 Avg rating: 4.1	—	—	485 major competitor apps
addition	73	100	42	69 12,796 competing apps Median installs: 150 Avg rating: 4.1	—	—	148 major competitor apps
improved	73	100	39	64 6,714 competing apps Median installs: 200 Avg rating: 4.1	—	—	129 major competitor apps
system	69	100	47	77 41,075 competing apps Median installs: 100 Avg rating: 4.1	—	—	376 major competitor apps
natural	72	100	42	69 12,977 competing apps Median installs: 200 Avg rating: 4.3	—	—	183 major competitor apps
line	72	100	44	71 17,995 competing apps Median installs: 200 Avg rating: 4.1	—	—	314 major competitor apps
target	73	100	40	66 9,342 competing apps Median installs: 150 Avg rating: 4.2	—	—	123 major competitor apps
types	71	100	44	72 19,715 competing apps Median installs: 200 Avg rating: 4.1	—	—	233 major competitor apps
drive	72	100	43	69 13,575 competing apps Median installs: 200 Avg rating: 4.0	—	—	230 major competitor apps
attack	72	100	39	63 5,458 competing apps Median installs: 300 Avg rating: 4.1	—	—	104 major competitor apps
cell	72	100	36	59 3,532 competing apps Median installs: 200 Avg rating: 4.1	—	—	61 major competitor apps
making	68	100	48	80 56,675 competing apps Median installs: 150 Avg rating: 4.2	—	—	744 major competitor apps
known	73	100	42	68 11,338 competing apps Median installs: 200 Avg rating: 4.1	—	—	180 major competitor apps

App Description

Non-small-cell lung cancer (NSCLC) is 1 of 2 main types of lung cancer. It develops from epithelial cells that line the lung airways and sacs, some of which produce mucus that lubricates and protects the lung. Cancer cells use a variety of ways to avoid the body’s natural defense—the immune system—to continue to grow, invade, and spread. In various types of NSCLC, molecular interactions between PD-1 on our immune system’s T-cells and PD-L1 on cancer cells drive whether or not the body’s immune system will attack a cancer cell. This program will look at the cellular underpinnings of NSCLC, as well as agents—known as checkpoint inhibitors—that target PD-1 or PD-L1 for improved management of this condition.

Users should seek a doctor's advice in addition to using this app and before making any medical decisions